Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out

 
• By Joseph Haas
  
business documents accounting with calculator and magnifying glass. concept for financial
Yescarta sales remain flat but Gilead's HIV franchise is setting sales records
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business